Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Dalton Venture

Founders Ning Huang Qi Sun

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 39
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 28
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.28
Key employees Soon
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • Medical
  • Biotechnology
  • Medical Device
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Dalton Venture:
Typical Co-investors
Dalton Venture is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Dalton Venture:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Pharmolix

Biopharma
Biotechnology
Medical
$15M14 Aug 2024 Beijing, Beijing, China

Mol Breeding

Agriculture
Biotechnology
Life Science
$38M30 Jul 2024 Shijiazhuang, Hebei, China

Astribot

Robotics
17 Jun 2024 Shenzhen, Guangdong, China

Kangyuan Medical

04 Jun 2024 Dalian Shi, Liaoning, China

Jichen Biotechnology

07 May 2024 Shijiazhuang, Hebei, China

Oushisheng Technology

03 Apr 2024 Beijing, Beijing, China

Sino-Biocan

Biotechnology
Genetics
Therapeutics
$15M04 Mar 2024 Beijing, Beijing, China

MacroLux

Health Care
Medical
15 Jan 2024 Shenzhen, Guangdong, China

Bingjing Smart

Health Care
Medical Device
02 Jan 2024 Suzhou, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Dalton Venture?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 39
Average round size 10M
Peak activity year 2023
Lead investments 6
Follow on index 0.28
Group Appearance index 0.85

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Pharmolix

Biopharma
Biotechnology
Medical
$15M14 Aug 2024 Beijing, Beijing, China

Mol Breeding

Agriculture
Biotechnology
Life Science
$38M30 Jul 2024 Shijiazhuang, Hebei, China

Astribot

Robotics
17 Jun 2024 Shenzhen, Guangdong, China

Kangyuan Medical

04 Jun 2024 Dalian Shi, Liaoning, China

Jichen Biotechnology

07 May 2024 Shijiazhuang, Hebei, China

Oushisheng Technology

03 Apr 2024 Beijing, Beijing, China

Sino-Biocan

Biotechnology
Genetics
Therapeutics
$15M04 Mar 2024 Beijing, Beijing, China

MacroLux

Health Care
Medical
15 Jan 2024 Shenzhen, Guangdong, China

Bingjing Smart

Health Care
Medical Device
02 Jan 2024 Suzhou, Jiangsu, China
Crunchbase icon

Content report

The following text will be sent to our editors: